Hutch News
Results per Page:
New Science Spotlight Articles
Every month, Fred Hutch postdoc writer/editors summarize two papers from each of our scientific divisions to stimulate collaborations across campus
March 20, 2023
Mutant KRAS signaling drives alternative splicing in lung cancer cells
From the Berger Lab, Human Biology Division
Neutrophils disguise tumors by synthesizing and secreting arginase
From the Houghton lab and collaborating Randolph lab, Clinical Research and Public Health Sciences Divisions
MacPherson Lab puts immunologically cold cancers in the hot seat with combination therapy
From the MacPherson and Srivastava Labs, Cancer Basic Biology and Cancer Immunology Programs, Cancer Consortium.
A liquid asset: Lung cancer tumor profiling from bronchoalveolar lavage fluid
From Dr. Viswam Nair, Clinical Research Division
Interactions between oncologists and patients – The lung cancer experience
From Dr. Casey Walsh, Fred Hutch Clinical Research Division, Dr. Morhaf Al Achkar, University of Washington, and colleagues
Uncovering cancer growth genes that have each other’s back when the other is down
From the Berger Lab, Human Biology Division
The patient voice: Insights into lung cancer screening
From the Triplette Group, Clinical Research Division
A chink in lung cancer’s armor
From the Berger Lab, Human Biology Division
MGA & MYC: mega-sized players in cancer progression
From the Eisenman Lab, Basic Sciences Division and the MacPherson Lab, Human Biology and Public Health Sciences Divisions
Cancer-busting broccoli sprout pills? It’s a thing.
Translational scientist’s ‘green chemoprevention’ research extends from eastern China to Seattle and now, into space
New insights into drug resistance in small cell lung cancer
Scientists discover a single gene’s outsized role in drug resistance — and use its vulnerability to re-sensitize tumors to chemotherapy in preclinical models
Dr. Alice Berger receives grant to study causes of lung cancer in never-smokers
$100K from the Prevent Cancer Foundation will allow her to link environmental factors to genetic signatures in tumors
Path to a targeted treatment for small-cell lung cancer?
Researchers show how common mutation in SCLC makes mouse tumors more vulnerable to certain cancer drugs
Fred Hutch team receives $7.5M NCI grant to improve cancer screening
PROSPR II consortium aims to refine detection of cervical, colorectal and lung cancers